Description of Invention:
The Public Health Service seeks a licensee to commercialize protein engineered human interferon alphas for treating and/or preventing a SARS-associated coronaviral infection in humans and other relevant mammalian species.
Inventors:
Kathryn C. Zoon (NCI) Renqui Hu (NCI) Joseph B. Bekisz (NCI)
Patent Status:
DHHS Reference No. E-278-2003/0 --
U.S. Provisional Application No. 60/567,083 filed 30 Apr 2004
PCT Application No. PCT/US2005/014800 filed 28 Apr 2005, which published as WO 2006/076014 on 20 Jul 2006
Related Technologies: DHHS Reference No. E-165-2004 -- SARS Coronavirus MVA Vaccines and Therapy
For Additional Information Please Contact: Michael Shmilovich J.D.
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301) 435-5019
Email: shmilovm@mail.nih.gov
Fax: (301) 402-0220